• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Towards an understanding of drug resistance in malaria: three-dimensional structure of Plasmodium falciparum dihydrofolate reductase by homology building.

作者信息

Lemcke T, Christensen I T, Jørgensen F S

机构信息

Institute of Pharmacy, University of Hamburg, Germany.

出版信息

Bioorg Med Chem. 1999 Jun;7(6):1003-11. doi: 10.1016/s0968-0896(99)00018-8.

DOI:10.1016/s0968-0896(99)00018-8
PMID:10428368
Abstract

A three-dimensional (3-D) model of dihydrofolate reductase (DHFR) from Plasmodium falciparum has been constructed by homology building. The model building has been based on a structural alignment of five X-ray structures of DHFR from different species. The 3-D model of the plasmodial DHFR was obtained by amino acid substitution in the human DHFR, which was chosen as template, modification of four loops (two insertions, two deletions) and subsequent energy minimization. The active site of P. falciparum DHFR was analyzed and compared to human DHFR with respect to sequence variations and structural differences. Based on this analysis the molecular consequences of point mutations known to be involved in drug resistance were discussed. The significance of the most important point mutation causing resistance, S108N, could be explained by the model, whereas the point mutations associated with enhanced resistance, N51I and C59R, seem to have a more indirect effect on inhibitor binding.

摘要

相似文献

1
Towards an understanding of drug resistance in malaria: three-dimensional structure of Plasmodium falciparum dihydrofolate reductase by homology building.
Bioorg Med Chem. 1999 Jun;7(6):1003-11. doi: 10.1016/s0968-0896(99)00018-8.
2
Molecular modeling of wild-type and antifolate resistant mutant Plasmodium falciparum DHFR.野生型和抗叶酸耐药性恶性疟原虫二氢叶酸还原酶的分子建模
Biophys Chem. 2002 Aug 2;98(3):287-300. doi: 10.1016/s0301-4622(02)00077-7.
3
An amino acid substitution in the Babesia bovis dihydrofolate reductase-thymidylate synthase gene is correlated to cross-resistance against pyrimethamine and WR99210.牛巴贝斯虫二氢叶酸还原酶-胸苷酸合酶基因中的一个氨基酸取代与对乙胺嘧啶和WR99210的交叉耐药性相关。
Mol Biochem Parasitol. 2004 Feb;133(2):209-19. doi: 10.1016/j.molbiopara.2003.08.013.
4
In silico screening against wild-type and mutant Plasmodium falciparum dihydrofolate reductase.针对野生型和突变型恶性疟原虫二氢叶酸还原酶的计算机筛选。
J Mol Graph Model. 2008 Apr;26(7):1145-52. doi: 10.1016/j.jmgm.2007.10.006. Epub 2007 Oct 18.
5
Rational drug design approach for overcoming drug resistance: application to pyrimethamine resistance in malaria.克服耐药性的合理药物设计方法:在疟疾中对乙胺嘧啶耐药性的应用。
J Med Chem. 1998 Apr 23;41(9):1367-70. doi: 10.1021/jm970845u.
6
Exploiting structural analysis, in silico screening, and serendipity to identify novel inhibitors of drug-resistant falciparum malaria.利用结构分析、计算机筛选和意外发现来鉴定耐药恶性疟原虫的新型抑制剂。
ACS Chem Biol. 2009 Jan 16;4(1):29-40. doi: 10.1021/cb8002804.
7
Identification of the optimal third generation antifolate against P. falciparum and P. vivax.鉴定针对恶性疟原虫和间日疟原虫的最佳第三代抗叶酸剂。
Mol Biochem Parasitol. 2005 Dec;144(2):198-205. doi: 10.1016/j.molbiopara.2005.08.014. Epub 2005 Sep 6.
8
Homology modeling of wild type and pyrimethamine/cycloguanil-cross resistant mutant type Plasmodium falciparum dihydrofolate reductase. A model for antimalarial chemotherapy resistance.恶性疟原虫野生型及乙胺嘧啶/环氯胍交叉耐药突变型二氢叶酸还原酶的同源建模。抗疟化疗耐药模型。
Biophys Chem. 2001 Jul 24;91(3):305-17. doi: 10.1016/s0301-4622(01)00180-6.
9
Insights into antifolate resistance from malarial DHFR-TS structures.从疟疾二氢叶酸还原酶-胸苷酸合成酶结构洞察抗叶酸耐药性。
Nat Struct Biol. 2003 May;10(5):357-65. doi: 10.1038/nsb921.
10
Lead discovery of inhibitors of the dihydrofolate reductase domain of Plasmodium falciparum dihydrofolate reductase-thymidylate synthase.恶性疟原虫二氢叶酸还原酶-胸苷酸合成酶中二氢叶酸还原酶结构域抑制剂的先导化合物发现
Biochem Biophys Res Commun. 1997 Jun 27;235(3):515-9. doi: 10.1006/bbrc.1997.6814.

引用本文的文献

1
Binding modes of 2,4-diaminoquinazoline and 2,4-diaminopteridine analogs to P. falciparum dihydrofolate reductase enzyme: Molecular docking studies.2,4-二氨基喹唑啉和2,4-二氨基蝶啶类似物与恶性疟原虫二氢叶酸还原酶的结合模式:分子对接研究
Indian J Pharm Sci. 2010 May;72(3):324-33. doi: 10.4103/0250-474X.70478.
2
Computer-aided molecular design of 1H-imidazole-2,4-diamine derivatives as potential inhibitors of Plasmodium falciparum DHFR enzyme.计算机辅助 1H-咪唑-2,4-二胺衍生物的分子设计,作为潜在的恶性疟原虫 DHFR 酶抑制剂。
J Mol Model. 2011 Apr;17(4):657-67. doi: 10.1007/s00894-010-0756-y. Epub 2010 Jun 5.
3
Targeting purine and pyrimidine metabolism in human apicomplexan parasites.
针对人类顶复门寄生虫中的嘌呤和嘧啶代谢
Curr Drug Targets. 2007 Jan;8(1):31-47. doi: 10.2174/138945007779315524.
4
Integration and mining of malaria molecular, functional and pharmacological data: how far are we from a chemogenomic knowledge space?疟疾分子、功能和药理学数据的整合与挖掘:我们距离化学基因组学知识空间还有多远?
Malar J. 2006 Nov 17;5:110. doi: 10.1186/1475-2875-5-110.
5
Homology building as a means to define antigenic epitopes on dihydrofolate reductase (DHFR) from Plasmodium falciparum.同源性构建作为一种确定恶性疟原虫二氢叶酸还原酶(DHFR)上抗原表位的方法。
Malar J. 2004 Jun 12;3:16. doi: 10.1186/1475-2875-3-16.